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Technical Report
Abstract
Purpose: The purpose of present study was to experimentally evaluate the dosimetric uncertainties in 3-dimensional conformal
radiotherapy (3DCRT), dynamic intensity modulated radiotherapy (D-IMRT), step-shoot (SS-IMRT), and volumetric modulated
arc therapy (VMAT) treatment delivery techniques due to intra- and inter-fractional target motion. Methods: A previously
treated lung patient was selected for this study and was replanned for 60 Gy in 30 fractions using four techniques (3DCRT,
D-IMRT, SS-IMRT, and VMAT). These plans were delivered in a clinical linear accelerator equipped with HexaPOD™ evo RT
System. The target dose of static QUASAR phantom was calculated that served as reference dose to the target. The QUASAR
respiratory body phantom along with patients breathing wave form and HexaPOD™ evo RT System was used to simulate the
intra-fraction and inter-fraction motions. Dose measurements were done by applying the intra-fractional and inter-fractional
motions in all the four treatment delivery techniques. Results: The maximum percentage deviation in a single field was -4.3%,
10.4%, and -12.2% for 3DCRT, D-IMRT and SS-IMRT deliveries, respectively. Similarly, the deviation for a single fraction was
-1.51%, -1.88%, -2.22%, and -3.03% for 3DCRT, D-IMRT, SS-IMRT and VMAT deliveries, respectively. Conclusion: The impact
of inter-fractional and intra-fractional uncertainties calculated as deviation between dynamic and static condition dose was
large in some fractions, however average deviation calculated for thirty fractions was well within 0.5% in all the four
techniques. Therefore, inter- and intra-fractional uncertainties could be concern in fewer fraction treatments such as
stereotactic body radiation therapy, and should be used in conjunction with intra- and inter-fractional motion management
techniques.
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Introduction
Treatment of upper abdomen and thorax using ionizing
radiation is challenging issue in the radiotherapy due to
inter- and intra-fractional movement.1 Intra-fraction motion
is caused mostly by the respiratory, cardiac, and
gastrointestinal system. Apart from respiratory motion
which varies from day to day, tumor and normal tissues can
also shrink, grow and shift in response to radiation therapy
and potentially to other concomitant therapies.2 Studies on
respiratory induced tumour motion have indicated that
major movement is in superior-inferior (SI) direction and
tumors located in the lower lobe of the lung exhibited the
greatest amount of motion along the SI axis.3,4 The motion of
the lung in SI direction play important role in dosimetric
uncertainties compared to lateral and anterior-posterior (AP)
motions during lung cancer radiotherapy.5 The
inter-fractional setup errors which arise as a result of
deviation of anatomic structures between the pre-treatment
position and planning computed tomography (CT), produce
deviation of delivered dose from planned dose affecting the
treatment accuracy.6Apart from these, relative movement of
target and multileaf collimator (MLC) known as interplay
effect is an important factor to be considered in treatment
delivery techniques that involve intensity modulation. The
interplay effect can also produce cold/hot spots within the
target. These sources of error become limiting factor in
achieving the goal of the radiotherapy.
Technical advances resulted in various techniques to manage
the inter- and intra-fractional motion such as breath-hold7,8,9
gating10,11, and tracking.12,13 Hence it is important to
investigate the dosimetric effect of techniques used for
delivery of radiotherapy treatments in context of respiratory
motion. The purpose of this study was to experimentally
evaluate the dosimetric uncertainties in 3-dimensional
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conformal radiotherapy (3DCRT), dynamic intensity
modulated radiotherapy (D-IMRT), step-shoot (SS-IMRT),
and volumetric modulated arc therapy (VMAT) treatment
delivery techniques due to intra- and inter-fractional target
motion
Methods and Materials
6-dimensional (6D) patient setup couch
HexaPOD™ evo RT System (Elekta Medical systems, USA)
was used in this study that enables to correct the setuperrors
in translational as well as in rotational direction (roll, pitch,
and yaw). Table 1 shows the range of movement of 6D
hexapod evo RT system. The 6D setup errors used in this
study were acquired from the daily portal verification images
of a real patient. The inter setup error was simulated by
these six directional shifts using Hexa POD 6D couch [Table
2]. The setup errors (mean ± SD) used was RL: 0.34 ± 0.53
cm, SI: 0.05 ± 0.30 cm, AP: 0.046 ± 0.33cm, Pitch: 0.43 ±
1.39, Roll: -0.63 ± 1.22deg and Yaw: 0.79 ± 1.13 deg. This
helps in achieving the dose delivery to an accuracy of ±5%
and spatial agreement of planned to delivered isodose lines of
±3 mm.
Quasar respiratory motion phantom
The intra-fractional respiratory motion was simulated using
the QUASAR™ (Modus Medical Devices Inc., London)
respiratory motion phantom, a state-of-the-art breathing
simulator [Figure 1]. It is comprised of programmable drive
unit, body oval and cylindrical inserts etc. The body oval
with dimension 30 cm × 20 cm × 12 cm weighs 20 kg to
approximate the average thorax region of human body. The
cylindrical inserts provide the means for dose measurement.
The insert can accommodate ionization chamber, thermo
luminescence dosimeters (TLD), gafchromic films, gel
dosimeter and optically stimulated luminescence etc. In this
study 0.6 cc ionization chamber (PTW Freiberg, Germany)
was used for the measurement of absorbed dose. The
movement of the insert was in the superior- inferior
direction as per the wave form acquired from Real-time
Position Management TM (RPM) system.
TABLE 1: Treatment range of 6D Hexapod evo System.
Translational treatment range at start position
Axis Translations from the zero position Movement Axis Rotation Movement
X Lateral ±30 mm Pitch Around the x-axis ±30
Y Longitudinal ±30 mm Roll Around the y-axis ±30
Z Vertical ±30 mm Yaw Around the Z-axis ±30
FIG. 1: Experimental setup: The QUASARTM respiratory phantom having insert connected to drive system on the Hexapod.
FIG 2: % Deviation in dose (with motion) from static in 3DCRT.
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TABLE 2: Patients setup error for 30 fractions.
No. of fraction X Y Z Yaw Pitch Roll
1 0.7 0.5 -0.1 0.1 -2.4 2.3
2 1.2 0.2 0.1 -0.6 -0.3 1.9
3 0.5 0.2 0.4 2.1 -0.6 -0.1
4 0.1 -0.2 0.1 1.4 -0.4 1
5 -0.7 0.3 0.1 2.5 -0.9 2.5
6 0.8 -0.6 0.1 -2.4 0.1 2
7 0.5 0.4 0 0.5 -1.6 -0.7
8 -0.3 0 0.4 1.7 -0.5 -1.2
9 0.4 -0.4 0.3 -1 0.2 -1.1
10 1.2 -0.3 0.5 1.2 -1 0.7
11 1 0.2 -0.5 -1.9 0.3 1.7
12 0.4 0.2 -0.1 1.7 2.3 -0.5
13 0.1 0.2 -0.2 -0.3 -1.4 0.4
14 0.3 -0.5 -0.7 -0.6 -0.3 1.3
15 0.9 0.3 -0.2 0.2 -0.1 0.6
16 0.3 0.1 -0.1 2.5 -0.3 -0.2
17 0.8 -0.3 0.2 1.9 -1.0 0.7
18 0.5 0.00 -0.4 -0.2 -2.6 -0.5
19 -0.3 -0.2 0.3 -0.1 -2.6 -0.5
20 0.2 -0.4 -0.2 0.1 -2.3 2.2
21 0.1 0.2 -0.2 -0.3 -1.4 0.4
22 0.4 0.2 -0.1 1.7 2.3 -0.5
23 0.8 -0.4 0.8 2.5 -0.4 1.6
24 -0.6 0.5 0.4 0.7 -2.0 -0.4
25 1.0 0.2 -0.5 -1.9 0.3 1.7
26 -0.3 0.1 0.4 -0.3 -2.1 1.5
27 0.2 0.2 -0.1 -1.2 -.20 1.8
28 -0.5 0.4 0.2 2.1 0.9 1.3
29 1.0 0.2 0.1 -0.5 -0.4 2.0
30 0.6 0.2 0.4 0.8 -0.6 1.8
A previously treated lung cancer patient was selected for this
study and was re-planned for 60 Gy in 30 fractions using
four treatment delivery techniques viz 5 field 3D CRT, seven
fields each in D-IMRT & SS-IMRT and single arc VMAT.
The 3D CRT plan was generated using CMC XiO (version
4.64.00; Computerized Medical System, St.Louis, MO) and
inverse planning was performed using Monaco (version 3.2;
CMS Inc., St. Louis, MO) treatment planning system (TPS).
Pre-treatment verification plans with maximum dose rate of
~ 700MU/min at the isocenter for 6 MV photon beam, were
created and exported to RV system Mosaiq, Elekta,
Mountain View, CA) for the treatment delivery using
clinical linear accelerator (Infinity, Elekta Medical systems,
USA) equipped with MLCi2, iViewGT, XVI (version 4.64.00)
and HexaPODTM.
The QUASAR™ phantom with the insert having 0.6 cc
ionization chamber, was placed on the HexaPOD™ evo RT
System and connected to drive system that was responsible
for the movement of target in SI direction as per the given
breathing waveforms. Treatment plan of a real lung cancer
patient was retrieved to the treatment delivery workstation.
This plan was executed in two arrangements.
Target dose in static condition
Treatment plan of each technique was executed on the
QUASARTM phantom in static condition (without any
intra-fractional and inter-fractional motion) keeping center
of the chamber and center of the field along the central
beam line with source to axis of the chamber distance (SAD)
100 cm. As shown in the [Table 3] dose values in each field
of each fraction were recorded from the electrometer
reading corrected for temperature, pressure, etc.
Target dose in dynamic condition
To incorporate the effect of inter-fractional (inter setup) and
intra-fractional (target) motion, each fraction was delivered
after introducing the inter setup error [Table 2] in the
HexaPOD™ evo RT system couch along with the
intra-fractional target motion according to individual patient
waveform. Thus, target moves around the isocentre in SI
direction during the delivery of radiation. In each fraction
initial breathing phases were introduced randomly. This was
done for 30 fractions in all the four techniques. Dose
received was calculated as done in Static condition for each
field of each fraction [Table 3]. The cumulative target dose
from each fraction in all the technique was compared with
the corresponding static doses to calculate percentage
deviations.
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Results
Dosimetric effect of intra- and inter-fractional target motion
was studied for 3DCRT, SS-IMRT, D-IMRT, and VMAT
treatment deliveries. The target dose measured for 120
fractions (30 fractions in each modality) using the 0.6 cc
ionization chamber with inter- and intra-fractional motion
in superior and inferior (SI) direction only, as well as for
static reference condition as depicted in [Table 3 (a), (b), (c)
and (d)]. Variation was found in daily fraction of each
technique between static dose and dose in dynamic
condition. There was large variation among the various
techniques. The maximum percentage deviation in dose in
dynamic condition compared to static doseina single field
was -4.3%, 10.8% and -12.2% for 3DCRT, D-IMRT,
SS-IMRT respectively. Similarly the % deviation for a single
fraction was (-1.51 ± 0.64%), (-1.88 ± 0.80%), (-2.22 ± 0.83%)
and (-3.03 ± 1.28%) for 3DCRT, D-IMRT, SS-IMRT and
VMAT as shown in the [Figure 2, 3, 4 and 5]. On the other
hand the percentage deviation of all the techniques was
reduced to less than 0.5% for the entire 30 fractions.
Difference in doses delivered by different techniques was
found statistically significant (p = 0.331, at confidence level
0.05) using ANOVA One-way analysis of variance of means
of % deviation from dose in static condition. Compared to
3DCRT the maximum deviation in dose was found in VMAT
technique (p = 0.800).
TABLE 3(a):Measured dose (cGy) in 5 fields of each fraction in three dimensional conformal radiotherapy in static and dynamic condition.
No. of
Fractions 1CRT 2CRT 3CRT 4CRT 5CRT
Static(cGy)
1 50.34 30.23 37.86 52.70 28.46
Dynamic(cGy)
1 50.33 30.20 37.78 52.73 28.49
2 51.20 30.30 36.80 52.84 28.47
3 49.58 30.56 37.96 52.05 28.39
4 48.91 30.98 38.27 51.29 28.17
5 50.24 30.48 37.40 51.90 28.18
6 48.57 31.30 38.26 50.52 27.93
7 48.911 31.33 39.03 50.30 27.69
8 50.85 30.51 37.11 52.74 28.49
9 50.45 30.51 38.11 52.57 28.39
10 50.23 30.53 38.39 52.17 28.26
11 50.85 30.28 37.64 52.80 28.53
12 51.35 29.59 37.51 54.86 29.13
13 50.66 30.75 36.95 52.95 28.68
14 50.34 30.83 37.47 52.19 28.32
15 49.19 30.12 38.89 52.64 28.60
16 51.35 30.17 36.47 53.99 28.90
17 51.11 29.86 36.61 54.78 29.17
18 50.57 30.27 37.38 53.18 28.69
19 50.52 30.86 36.97 52.56 28.53
20 48.99 31.02 38.75 51.02 27.94
21 50.66 30.60 36.74 52.91 28.64
22 49.54 30.20 37.93 53.50 28.97
23 50.46 30.13 37.61 51.75 28.15
24 50.67 30.24 37.30 53.27 28.50
25 50.97 29.85 37.61 52.96 28.37
26 50.74 29.62 37.44 53.86 28.78
27 49.41 30.40 38.87 51.21 27.93
28 49.74 30.47 38.02 51.81 28.19
29 50.33 30.83 39.22 51.80 28.39
30 49.24 31.28 37.58 52.33 29.34
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TABLE 3(b): Measured dose (cGy) in 7 fields of each fraction in dynamic intensity modulated radiotherapy in static and dynamic condition.
No. of
Fractions 1DIMRT 1DIMRT 1DIMRT 1DIMRT 1DIMRT 1DIMRT 1DIMRTStatic(cGy)
48.20 32.98 18.16 27.59 36.88 40.60 35.54
Dynamic(cGy)
1 49.58 32.34 18.65 29.41 36.79 40.56 34.55
2 50.60 33.08 18.37 27.82 37.02 39.12 35.54
3 47.03 31.41 17.70 27.98 37.29 41.30 33.48
4 47.80 31.33 18.10 27.79 35.16 40.90 36.85
5 48.56 32.06 18.19 27.24 39.13 37.44 34.21
6 47.91 31.078 17.50 27.22 38.98 41.36 34.43
7 47.21 34.22 18.02 29.50 37.33 40.27 32.40
8 45.95 33.15 18.15 27.08 36.96 40.66 35.61
9 46.56 32.89 18.33 28.55 34.36 37.45 37.31
10 48.64 33.43 18.28 28.22 36.29 41.40 34.31
11 48.19 34.08 18.01 27.32 37.85 39.82 34.87
12 43.66 34.53 17.63 28.01 40.98 43.09 35.26
13 50.31 33.45 18.23 25.05 40.28 41.38 33.76
14 47.94 32.52 17.64 27.11 37.62 41.18 35.86
15 48.86 31.42 18.00 28.21 38.00 41.72 35.08
16 48.17 32.73 18.52 26.04 38.94 39.94 37.68
17 46.36 32.63 18.10 28.06 40.49 40.34 34.44
18 47.97 32.31 17.98 27.72 38.29 42.56 34.50
19 49.16 32.84 18.34 27.18 36.54 39.48 36.70
20 45.97 31.33 18.46 27.85 36.00 41.24 37.53
21 51.78 32.19 19.12 25.65 37.21 38.56 34.62
22 48.94 31.57 17.32 27.99 36.99 40.85 33.10
23 44.46 32.74 18.08 27.47 37.12 42.70 36.43
24 50.09 33.15 19.28 27.02 38.71 38.04 35.53
25 48.31 36.26 17.35 26.46 35.65 39.14 35.07
26 47.67 33.55 17.47 27.84 38.98 39.81 35.05
27 48.25 32.65 18.12 28.67 35.26 41.01 35.44
28 50.02 32.96 18.25 27.95 37.59 37.46 34.48
29 46.51 33.56 18.29 27.46 37.34 41.13 35.88
30 47.79 32.43 17.59 27.04 37.52 41.05 35.67
FIG. 3: % Deviation in dose (with motion) from static in DIMRT.
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TABLE 3(c): Measured dose (cGy) in 7 fields of each fraction in step & shoot intensity modulated radiotherapy in static and dynamic condition.
No. of
Fractions
1SSIMRT 2SSIMRT 3SSIMRT 4SSIMRT 5SSIMRT 6SSIMRT 7SSIMRT
Static (cGy)
38.56 48.90 17.47 22.49 31.01 40.37 38.47
Dynamic (cGy)
1 38.90 49.00 17.63 22.52 31.20 40.17 37.99
2 38.95 50.07 17.62 21.86 31.10 42.71 36.45
3 39.71 49.51 17.63 22.96 31.751 39.11 37.81
4 39.62 47.80 17.86 22.88 31.97 38.33 36.72
5 40.26 51.21 18.04 22.53 31.00 39.88 33.76
6 39.28 47.69 18.26 23.67 32.61 37.47 36.21
7 39.80 47.64 18.16 24.44 32.78 37.70 36.63
8 39.77 52.39 17.98 22.27 30.63 40.83 36.09
9 39.62 48.77 17.62 22.90 31.39 40.15 37.63
10 40.40 50.55 17.66 22.74 31.62 40.26 38.63
11 39.07 49.41 17.48 22.23 31.35 41.17 35.41
12 37.61 48.52 17.20 21.77 31.77 42.40 40.21
13 38.67 50.44 17.85 21.82 31.07 40.16 38.80
14 40.29 50.76 17.95 23.03 31.31 39.84 36.36
15 38.66 46.17 17.63 22.77 32.14 39.09 38.90
16 36.89 51.04 17.48 21.17 31.27 42.05 39.32
17 38.94 49.71 17.33 21.47 32.90 40.99 41.17
18 37.67 50.87 17.59 21.79 31.01 40.51 38.76
19 39.12 49.08 17.99 22.04 31.23 39.73 38.12
20 39.64 47.87 17.95 23.94 32.00 38.12 36.04
21 38.62 51.11 17.60 21.72 30.95 39.97 38.38
22 36.87 47.01 17.88 22.15 31.60 39.13 40.99
23 40.58 51.54 17.74 22.63 31.33 40.00 37.31
24 37.58 49.40 17.50 22.65 30.87 40.51 38.77
25 38.47 49.33 17.04 22.45 30.32 41.36 37.63
26 36.61 50.38 17.42 21.86 31.12 41.20 38.70
27 39.99 47.57 17.87 24.23 31.61 38.59 36.22
28 40.09 50.21 17.79 23.24 31.50 39.01 35.65
29 39.50 49.57 17.88 22.15 31.51 39.92 36.10
30 39.55 48.14 17.40 22.70 31.62 39.56 38.41
FIG. 4: % Deviation in dose (with motion) from static in SSIMRT.
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TABLE 3(d): Measured dose (cGy) in each fraction in single arc of
Volumetric Arc Modulated Radiotherapy in static and dynamic
condition
No. of
Fractions
VMAT
Static
237.596
Dynamic
1 240.15
2 230.38
3 235.99
4 238.50
5 236.68
6 240.09
7 235.48
8 234.71
9 236.61
10 234.15
11 238.75
12 241.11
13 240.43
14 237.05
15 232.83
16 233.93
17 241.76
18 240.40
19 239.15
20 238.94
21 238.35
22 239.33
23 236.52
24 241.35
25 233.68
26 239.82
27 234.89
28 231.42
29 234.89
30 239.02
FIG. 5: % Deviation in dose (with motion) from static in VMAT.
Discussion
Both inter-fraction and intra-fraction motion affects the
delivered dose distribution. Patients breathing pattern can
vary during imaging and therapy in terms of amplitude and
period etc.14 in the present study, authors used the ionization
chamber for the measurement of deviation in dose in
dynamic condition from the static one in different
techniques and deviation up to 2.22% in SS-IMRT was
found. Schaefer et al.15 made a study to find out whether
breathing induced organ motion may cause over dosing or
under dosing in the step-shoot IMRT of lung cancer. The
measurement of dose was performed using ionization
chambers in different places inside the phantom. The dose
differences between static and moving target was from
−2.4% and +5.5%. They concluded that at least in step-shoot
IMRT the breathing effects are of secondary importance.
To manage inter- and intra-motions, a conventional and
most popular method of adding the margin to gross tumour
volume (GTV) is used. The treatment plan used in this study
was created using 5 mm margin to GTV to produce the
clinical target volume (CTV). Planning target volume (PTV)
was created by adding 10 mm margin in CTV16, besides these
margins, a significant deviation up to 3.03% (VMAT) in a
single fraction was found in dynamic dose compared to static
one. At the same time these margins causes irradiation of
normal tissue that results in the form of complications.
In the present study, difference in static dose and dose in
dynamic condition was recorded though margins were
present in GTV and CTV. The choice of adding more
margins is always not a good way of practice especially for
patients having wide range of tumour motion.17 Nøttrup et
al. found that method of margin is not always sufficient to
overcome the problem of inter-fraction and intra-fraction
motion. In their study they quantified the breathing
variations over full course of radiotherapy and found that
margins to account respiratory motion in lung tumour
should include inter-fraction variations in breathing on the
basis of individual assessment.18
In this study two modes of treatment were used viz
conventional or non-modulated (3DCRT) and modulated
(SS-IMRT, D-IMRT, and VMAT). The total error in position
of tumor, is sum of relative movement between
tumour-bone (intra-fraction) and bone-treatment room
(inter-fraction). Intra-fractional motion causes averaging of
the dose distribution whereas inter-fraction motion causes
shift of dose distribution.19 In case of 3DCRT technique
intra-fraction motion is found to be a cause behind the dose
deviation as the dose gradient at the center of field is very
small. In case of modulated beam (IMRT), in addition to
intra-fraction motion dose gradient within the field is also
present. This is evident from the results of this study as least
deviation (~1.5%) in dose in dynamic condition from static
dose was found in 3DCRT compared to techniques involving
modulation of beams (~3.0%) such as VMAT. The relative
motion between multileaf collimator and tumour known as
interplay effect can be a cause of dose difference. From the
results of this study it was found that interplay effect dose
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not play significant role in techniques involving large no. of
fractions as for as total delivered dose is concerned. In this
study, deviation in dose delivered in dynamic condition from
dose in static condition in individual fractions was recorded
similar to other studies using other means of dose
measurement.20, 21
Similar to this experimental study, Bortfeld et al.22 modeled
(mathematically) the effects of intra-fraction motion on
IMRT dose delivery and found that over all dose was just
weighted average of static one. They concluded that one
should not concern so much for the intra-fraction motion in
highly fractionated IMRT treatment delivery. As a
consequence, techniques for the management of organ
motion reduces margin that enables dose escalation that is
the one of the goals of radiotherapy. The accuracy of the
results presented in this study may vary for different clinical
conditions such as complexity of treatment plan, dose rate,
etc. As dose was measured using large volume ion chamber,
i.e. 0.6 cc for a single patient, it is required to extend this
study to understand the three dimensional dose variations in
relations to target and critical organs in cohort of patients. It
is also recommended to further investigate the intra- and
inter-fractional errors in the lung cancer patients treated
with the stereotactic body radiation therapy (SBRT) VMAT
technique.24, 25
Conclusion
The impact of inter-fractional and intra-fractional
uncertainties calculated as deviation between dynamic and
static condition dose was large in some fractions, however
average deviation calculated for thirty fractions was well
within 0.5% in all the four techniques. Therefore, inter- and
intra-fractional uncertainties could be concern in fewer
fraction treatments such as SBRT and should be used in
conjunction with intra- and inter-fractional motion
management techniques.
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